These primed T cells differentiate into tumor-specific cytotoxic T cells (CTL) that are capable of infiltrating the brain tumor environment and lyse tumor cells by the perforin/granzyme and Fas–FasLigand pathways [160]. The gene discussed is PRF1; the disease is neoplasm.